Venous thromboembolism prophylaxis in Colombian surgical and medical patients: Results for Colombia of the ENDORSE study;Profilaxis de la tromboembolia venosa en pacientes colombianos de tratamiento médico o quirúrgico: Resultados para Colombia del estudio ENDORSE

Biomedica

Volumn 31, Issue 2, 2011, Pages 200-208

  Dennis, Rodolfo J ^a,b   Roa, Jairo H ^c   Villadiego, Juan ^d   Méndez, Freddy ^e   Vieda, Elías ^f   Restrepo, Héctor ^a  

^a FUNDACIÓN CARDIOINFANTIL INSTITUTO DE CARDIOLOGÍA   (Colombia)

^b PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^c Fundacion Santafe de Bogota   (Colombia)

^d Programa de hospitalización Geriátrica Siéntete como en casa   (Colombia)

^e Departamento de Medicina Interna   (Colombia)

^f UNIVERSIDAD DEL VALLE   (Colombia)

Author keywords

Drug prescriptions; General surgery; Risk management; Thrombosis prevention control; Venous thromboembolism epidemiology

Indexed keywords

EID: 84856189514     PISSN: 01204157     EISSN: None     Source Type: Journal    
DOI: 10.7705/biomedica.v31i2.304     Document Type: Article

References (24)

1. Dennis R, Rojas MX, Molina A. Curso clínico y supervivencia en embolia pulmonar: resultados del registro multicéntrico colombiano (EMEPCO). Acta Méd Colomb. 2008;33:111-6.
2. Nieto JA, Monreal M, RIETE Investigators. Recurrent venous thromboembolism in men and women. N Engl J Med. 2004;351:2015-8.
3. Abuabara J, Acero R, Archila PE, Alí A, Bermúdez M, Bohórquez R, et al. II Consenso colombiano de tromboembolismo venoso. Acta Méd Colomb. 2005;30:241-6.
4. Geertz WH, Bergqvitz D, Pineo GF. Prevention of venous thromboembolism. En: The 8th ACCP Conference on Antithrombotic and Thrombolitic Therapy. Chest. 2008;133:381S-453S.
5. Nicolaides AN, Fareed J, Kakkar AK. Prevention and treatment of venous thromboembolism. International consensus statement. Int Angiol. 2006;25:101-61.
6. Dennis R, Acevedo JR, Restrepo H. ¿Es apropiada la profilaxis actual del tromboembolismo venoso en pacientes médicos? Evaluación de desenlaces colombianos en el Registro Internacional sobre Prevención Médica del TEV (IMPROVE). Acta Méd Colomb. 2009;34:11-6.
7. Dennis R, Niño de A MN, Salazar MS. Encuesta nacional sobre tromboembolismo venoso en población hospitalaria. Acta Méd Colomb. 1996;21:55-63.
8. Tapson VF, Decousus H, Pini M. VTE prophylaxis in acutely ill hospitalized medical patients: Findings from the international medical prevention registry on VTE. Chest. 2007;132:936-45.
9. Cohen AT, Tapson VF, Bergmann JF. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study). Lancet. 2008:371:387-94.
10. Samama MM, Cohen AT, Darmon JY. A comparison of enoxaparin with placebo for the prevention of VTE in acutely ill medical patients. N Eng J Med. 1999;341:793-800.
11. Leizorovicz A, Cohen AT, Turpie AG. A randomized placebo controlled trial of dalteparin for the prevention of VTE in acutely ill medical patients. Circulation. 2004;110:874-9.
12. Cohen AT, Davidson BL, Gallus A. Efficacy and safety of fondaparinux for the prevention of VTE in older acute medical patients. BMJ. 2006;332:325-9.
13. Geertz WH, Pineo GF, Heit JA. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:338S-400S.
14. Kahn SR, Panju A, Geerts W. Multicenter evaluation of the use of VTE profilaxis in acutely ill medical patients in Canada. Thromb Res. 2007;119:145-55.
15. Menajobsky LB, Spandorfer J. Benefits of more aggressive VTE prophylaxis in hospitalized medical patients. Cleve Clin J Med. 2004;71:947-8.
16. Scaglione L, Piobbici M, Pagano E. Implementing guidelines for VTE profilaxis in a large Italian teaching hospital: Lights and shadows. Haematologica. 2005;90:678-84.
17. Chopard P, Dorffler-Melly J, Hess U. Venous thromboembolism prophylaxis in acutely ill medical patients: Definite need for improvement. J Intern Med. 2005;257:352-7.
18. Hernández J, Dennis R, Londoño D. Evaluación de la concordancia entre estrategias de profilaxis de TEV en paciente médico en un hospital universitario, Bogotá D.C., 2007-2008. Acta Méd Colomb. 2009;34:4-10.
19. Millar JA. Selection of medical patients for prophylaxis of venous thromboembolism based on analysis of the benefit-hazard ratio. Intern Med J. 2009;39:606-12.
20. Douketis JD. Prevention of venous thromboembolism in hospitalized medical patients: Addressing some practical questions. Curr Opin Pulm Med. 2008;14:381-8.
21. Labarere J, Bosson JL, Sevestre MA. Intervention targeted at nurses to improve venous thromboprophylaxis. Int J Qual Health Care. 2007;19: 301-8.
22. Kucher N, Koo S, Quiroz N. Electronic alerts to prevent VTE among hospitalized patients. N Eng J Med. 2005;352:969-77.
23. Pham DQ, Pham AQ, Ullah E. Evaluating the appropriateness of thromboprophylaxis in an acute care setting using a computerised reminder, through order-entry system. Int J Clin Pract. 2008;62:134-7.
24. Piazza G, Goldhaber SZ. Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. Am J Med. 2009;122:230-2.